James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY.
Blood Adv. 2024 Jun 11;8(11):2612-2621. doi: 10.1182/bloodadvances.2023011804.
Patients with acute myeloid leukemia (AML) often undergo physical decline leading to negative outcomes. Identification of distinct trajectories may help guide clinical decision-making and supportive care interventions. We built group-based trajectory models (GBTM) to find trajectories of change in the Functional Assessment of Cancer Therapy Physical Well-Being (FACT-PWB) subscale (up to 5 time points over 0 to 200 days of follow-up) using data from adults with newly diagnosed AML in 4 supportive care studies. We also estimated the association of baseline characteristics (age, marital status, education, AML risk, baseline FACT-PWB, depression, and anxiety) with group membership. Among 343 patients with ≥2 FACT-PWB scores, mean age was 69.6 years (standard deviation, 12.1); most had intermediate-risk AML (n = 178 [51.8%]), received intensive treatment (n = 244 [71.1%]), and died during follow-up (n = 199 [58.0%]). The GBTM with 4 distinct trajectories showed the best fit. The largest group (n = 153 [45.0%]) showed slight improvement, whereas the smallest (n = 8 [2.4%]) experienced early decline with later improvement. Baseline FACT-PWB was the only characteristic statistically significantly associated with group membership. Adults with AML show distinct trajectories of physical well-being, and many experience some decline. Exploring trajectories of self-reported and objective physical function may inform decision-making and interventions. These trials were registered at www.ClinicalTrials.gov as #NCT02975869, #NCT03310918, and #NCT03372291.
急性髓细胞白血病(AML)患者常出现身体机能下降,导致不良结局。识别不同的轨迹可能有助于指导临床决策和支持性护理干预。我们使用 4 项支持性护理研究中初诊 AML 成人的数据,构建基于群组的轨迹模型(GBTM),以确定功能评估癌症疗法身体状况(FACT-PWB)子量表(最多 5 个时间点,随访时间为 0 至 200 天)的变化轨迹。我们还估计了基线特征(年龄、婚姻状况、教育程度、AML 风险、基线 FACT-PWB、抑郁和焦虑)与群组归属的关系。在≥2 次 FACT-PWB 评分的 343 名患者中,平均年龄为 69.6 岁(标准差 12.1);大多数患者为中危 AML(n=178[51.8%]),接受强化治疗(n=244[71.1%]),随访期间死亡(n=199[58.0%])。具有 4 个不同轨迹的 GBTM 具有最佳拟合度。最大的群组(n=153[45.0%])表现出轻微改善,而最小的群组(n=8[2.4%])则表现出早期下降,随后逐渐改善。基线 FACT-PWB 是唯一与群组归属具有统计学显著关联的特征。AML 成人表现出不同的身体状况轨迹,许多人经历了一些下降。探索自我报告和客观身体功能的轨迹可能有助于决策和干预。这些试验在 www.ClinicalTrials.gov 上注册为 #NCT02975869、#NCT03310918 和 #NCT03372291。